Bray Capital Advisors Novartis Ag Transaction History
Bray Capital Advisors
- $387 Million
- Q2 2024
A detailed history of Bray Capital Advisors transactions in Novartis Ag stock. As of the latest transaction made, Bray Capital Advisors holds 467 shares of NVS stock, worth $53,214. This represents 0.01% of its overall portfolio holdings.
Number of Shares
467
Previous 467
-0.0%
Holding current value
$53,214
Previous $45,000
8.89%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.39 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.39 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$845 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$844 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$677 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $245B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...